Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality.
作者信息
Stephenson J
出版信息
JAMA. 1995 Oct 18;274(15):1183-4.
PMID:7563492
Abstract
摘要
相似文献
1
Other AIDS drug regimens beat AZT alone, reduce clinical progression and mortality.
JAMA. 1995 Oct 18;274(15):1183-4.
2
Confirmation for combination AIDS therapy.
Science. 1995 Oct 6;270(5233):33.
3
AZT combination trial shows positive results.
Nature. 1995 Sep 28;377(6547):277. doi: 10.1038/377277b0.
4
Study results at a glance.
AIDS Alert. 1995 Nov;10(11):134.
5
Studies of zidovudine in combination with didanosine and zalcitabine.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S52-6.
6
Studies confirm value of early and combination treatments.
Posit Aware. 1995 Nov-Dec;VI(6):8.
7
ACTG 175 and Delta.
GMHC Treat Issues. 1995 Oct;9(10):2-3.
8
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.
N Engl J Med. 1996 Oct 10;335(15):1099-106. doi: 10.1056/NEJM199610103351503.
9
Making sense of 175 and Delta.
GMHC Treat Issues. 1995 Oct;9(10):4.
10
ACTG 175: new insights into treating patients with intermediate-stage HIV disease.
NIAID AIDS Agenda. 1995 Dec:4-5.
引用本文的文献
1
Current knowledge and future prospects for the use of HIV protease inhibitors.
Drugs. 1996 May;51(5):701-12. doi: 10.2165/00003495-199651050-00001.
2
Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection.
Drugs. 1996 Jul;52(1):93-112. doi: 10.2165/00003495-199652010-00007.
Zotero 插件